From Outsourcing to Strategic Alignment: The Future of CRO Partnerships in Biotech Building CRO Partnerships That Drive Speed, Continuity, and Clinical Success

As clinical development grows more complex and globally interconnected, biotech companies are under increasing pressure to build CRO partnerships that deli...

May 15, 2026 | Friday | Interaction
Andelyn Biosciences Launches LVV Curator® Platform to Accelerate Lentiviral Vector Manufacturing from Discovery to Clinic

New platform leverages the established Curator® platform methodology to industrialize Lentivirus processes from concept to clinic.   Andelyn Bio...

May 15, 2026 | Friday | News
Cytiva Secures FDA AMT Designation for ELEVECTA Cell Line, Advancing Next-Generation AAV Manufacturing

The FDA AMT designation recognizes technologies that demonstrate the potential to significantly improve the quality, reliability, and ...

May 15, 2026 | Friday | News
Inside the Sterile Manufacturing Boom: Symbiosis Expands Capacity for the Next Generation of Biopharma

  As biologics, advanced therapies, and specialised injectable medicines continue to reshape the pharmaceutical landscape, the demand for agile and h...

May 15, 2026 | Friday | Interaction
MacroGenics Sells Maryland Biologics Manufacturing Operations to Bora Pharmaceuticals for $122.5 Million

•MacroGenics to receive $122.5 million upfront payment from Bora upon closing•Transaction includes transfer of manufacturing site, CDMO operati...

May 13, 2026 | Wednesday | News
Delos Capital and AP Biosciences Launch Venture Creation Partnership to Advance Next-Generation Immunology Therapies

Partnership combines venture creation and biologics discovery to accelerate novel medicines through human clinical proof of concept First-of-its-kind ...

May 13, 2026 | Wednesday | News
argenx Secures FDA Expansion for VYVGART Across All Generalized Myasthenia Gravis Serotypes

VYVGART and VYVGART Hytrulo are the first and only approved treatments for all serotypes of adult patients living with gMG – anti-AChR-Ab positiv...

May 12, 2026 | Tuesday | News
Pierre Fabre Aligns with FDA on Pathway to Resubmit Tabelecleucel BLA for Rare EBV-Driven Post-Transplant Lymphoma

Pierre Fabre Pharmaceuticals, Inc. (PFP), announces it has aligned with FDA on a potential path forward for resubmission of the BLA for tabelecleucel, an...

May 11, 2026 | Monday | News
GI Partners Completes Acquisition of Charles River’s CDMO and Cell Solutions Businesses, Launches Rose BioSolutions

Creates Standalone Leader in Advanced Therapy Manufacturing with Decades of Proven Experience and Continued Commitment to Client Service Dedicated Resou...

May 11, 2026 | Monday | News
FUJIFILM Corporation Unveils Novel Cyclic Peptide Screening Technology for Challenging Membrane Protein Drug Targets

FUJIFILM Corporation announced that it has developed an innovative screening methodology for cyclic peptides exhibiting high affinity toward membrane pro...

May 11, 2026 | Monday | News
ArriVent BioPharma Secures FDA IND Clearance for Dual-Target ADC ARR-002 in Ovarian and Endometrial Cancers

Superior efficacy and favorable tolerability in animal models support the potential of ARR-002 to overcome limitations of single-target approaches Pha...

May 08, 2026 | Friday | News
Silo Pharma Launches Ibogaine-Based TBI Therapeutics Initiative Amid Growing Federal Support for Psychedelic Medicine Innovation

New initiative from Silo Pharma designed to align with federal actions to accelerate mental health innovation using psychedelic medicines Silo Pharma ta...

May 08, 2026 | Friday | News
Eli Lilly and Company Bets US$4.5 Billion on Indiana to Build the Future of Pharmaceutical Manufacturing

Eli Lilly and Company has announced an additional US$4.5 billion investment into its Indiana manufacturing network, deepening one of the mo...

May 07, 2026 | Thursday | Analysis
Amgen Invests Additional $300 Million to Expand U.S. Biomanufacturing Capacity in Puerto Rico

Investment Strengthens American Manufacturing, Supply Chain Resilience and Next-Generation Technology Amgen announced plans to invest an additional $300...

May 06, 2026 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close